REPROS THERAPEUTICS INC - *W EXP 02/08/201 (RPRXZ)

CUSIP: 76028H126

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / *W EXP 02/08/201
Total 13F shares
49,354
Share change
0
Total reported value
$230,000
Price per share
$4.65
Number of holders
2

Quarterly Holders Quick Answers

What is CUSIP 76028H126?
CUSIP 76028H126 identifies RPRXZ - REPROS THERAPEUTICS INC - *W EXP 02/08/201 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REPROS THERAPEUTICS INC - *W EXP 02/08/201 (RPRXZ) as of Q2 2015

As of 30 Jun 2015, REPROS THERAPEUTICS INC - *W EXP 02/08/201 (RPRXZ) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,354 shares. The largest 2 holders included SPRINGBOK CAPITAL MANAGEMENT, LLC and UBS Group AG. This page lists 2 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.